WisdomTree Has Launched A ‘Biology Revolution’ Exchange-Traded Fund (ETF) To Monitor The Leaders In Biotechnology And Genetics
In Frankfurt and London, WisdomTree created an exchange-traded fund (ETF) which monitors an array of major biotechnology and genetics firms. The WisdomTree Bio Revolution UCITS ETF monitors the WisdomTree Bio Revolution ESG Screened Indexes and has a payout ratio of 0.45 percent. One of the world’s greatest technological visionaries, Dr. Jamie Metzl, has consulted the organization.\ “The biological transformation is presenting a significant opportunity to invest comparable to the